FindTrial
Sign In

A study to evaluate post operative analgesic effects of intraperitoneal instillation of bupivacaine with morphine and bupivacaine with buprenorphine for laproscopic cholecystectomy

Evaluation of post operative analgesic effects of intraperitoneal instillation of bupivacaine with morphine and bupivacaine buprenorphine for laparoscopic cholecystectomy : A double blind comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048937
Enrollment
60
Registered
2023-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bupivacaine and Buprenorphine: Single Injection of 0.25% Bupivacaine and 0.3 mg Buprenorphine Control Intervention1: Bupivacaine and Morphine: Single Injection of 0.25% Bupivacaine and

Sponsors

Dr Ramesh Kumar PB
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to give written informed consent. 2. ASA physical status I and II patients. 3. Patients undergoing elective laparoscopic surgeries.

Exclusion criteria

Exclusion criteria: 1. Patients having a known allergy to the study drug. 2. Pregnancy

Design outcomes

Primary

MeasureTime frame
To assess analgesic effectsTimepoint: Pain Assessment will be done at 0 minutes,30 minutes, 1 hour, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours—

Secondary

MeasureTime frame
Overall Safety of drugsTimepoint: 0 minutes,30 minutes, 1 hour, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours—

Countries

India

Contacts

Public ContactDr Niveditha B

BGS Global Institute of Medial Sciences

geetp11@gmail.com9739945846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026